Creska™ is a live “Off-The-Shelf” Adipose Derived Cellular Allograft of live young human cellular factors and proteins which does not require an individual to undergo liposuction. Creska’s younger cellular factors and proteins make it a great stand-alone product or the perfect complement to be used with FDA Cleared Devices such PRP kits where skin and fat naturally exist so that all uses are homologous.
Creska™ meets all the criteria established by the U.S. FDA for HCT/Ps that are regulated solely under Section 361 of the PHS Act, and subject to 21CFR 1271.
​
Disclaimer: Creska™ is not intended for transplantation and is not HLA type matched between a donor and a recipient for any type of transplantation or intravenous use. HLA (Human Leukocyte Antigen) Tissue Typing is a procedure in which the tissues of a prospective donor and recipient are tested for compatibility prior to transplantation. Mismatched donor and recipient tissues can lead to rejection of the tissues. Creska™ is strictly for topical, cosmetic and subcutaneous use. This product is not intended for use in the treatment of any disease or condition.
​
​
What is Creska™?
Creska™ is derived from liposuction technology known to produce high cell viability from thoroughly screened donors and its intended use is for subcutaneous injection only where skin and fat naturally exist. Creska contains a high concentration of live, pure human derived cellular factors and proteins.
Creska™ is produced in the United States by an FDA registered lab that is also conducting multiple FDA approved clinical trials in the regenerative medicine industry.
General Application Guidelines
Creska™ can be used anywhere where fat or skin naturally exists subcutaneously injected or applied topically.
​ Creska™ works as a stand-alone product or as a complement to many established PRP or other protocols.
​
Creska was created on the premise that adding younger cells and proteins to aging populations will aid the body in healing in the way nature intended it to.
Creska with PRP or PRFM: We believe that utilizing Creska as a compliment to natural autologous signaling such as platelet derived growth factors should enhance regeneration. Creska™ is an affordable Off-The-Shelf product that should be offered to many PRP and PRFM candidates.
How does Creska™ work?
Creska™ is derived from dermal adipose tissue that is actually classified as skin. Creska is a homologous Adipose Derived Cellular Allograft that behaves in the skin as it was naturally intended to perform. The intent is to aid in the repair, or replaced damaged tissue reconstructs and replaces skin tissue while supplementing natural functions. Creska™ is composed of the same cytokines and growth factors-including collagen, elastin, hyaluronic acid, proteins, nano particles, extra cellular communication mechanisms, stem cells, and human derived cellular factors that exist in tissue to help repair defects where they may exist.
Creska™ as a stand-alone product or when offered as a complement to FDA Cleared PRP and PRFM Kit applications, or other autologous treatments should work in conjunction with a person’s own cell signaling and Platelet Derived Growth Factors while adding cushioning and support for tissue, energy storage in the form of lipids and structure of the dermis with the addition of younger cellular factors. It can be used for the repair of cosmetic defects in the skin, repair of injured skin due to surface wounds, as well as provide structural components that may assist in the development of tissue structure such as filling gaps in the skin structure and hair follicles.
